TELNET Holding has published its business indicators for the second quarter and first half of 2026. The Group reported overall performance marked by higher consolidated revenue and a net improvement in operating profitability.
As of June 30, 2026, the Group’s consolidated operating income stood at TND 44 million, compared with TND 42.5 million a year earlier, representing a 3.3% increase.
In the second quarter of 2026 alone, revenue reached TND 24.6 million, compared with TND 23 million in the second quarter of 2025.
R&D as a true growth engine
The half-year performance is driven almost entirely by the strength of the Engineering Research and Development (R&D) Division.
Accounting for 81.2% of the Group’s operating income at the end of June 2026, the division recorded annual growth of 14%, reaching a turnover of TND 35.7 million.
According to Group management, this momentum was fueled by both a slight increase in business volume with long-standing partners and, above all, a significant shift in business activity, with a new operating contract in the medical sector.
EBITDA surges by more than 23%
One of the key highlights of this report is the company’s tight control over operating expenses, which increased by only 0.3% to TND 37.1 million, despite a 6.1% rise in personnel expenses to TND 27.8 million.
This financial discipline, combined with the acquisition of high-value-added contracts, enabled the consolidated EBITDA margin to improve significantly by 23.3%, reaching TND 6.8 million.
The EBITDA margin rose to 15.54%, compared with 13.02% as of June 30, 2025. In the second quarter of 2026, the margin climbed even further to 15.86%.
